Related Articles
Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation
KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy
Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification
High frequency of microsatellite instability and its substantial co‑existence with <em>KRAS</em> and <em>BRAF</em> mutations in Vietnamese patients with colorectal cancer
Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review)